Premature Ejaculation Treatment Global Market Report 2024

Description

Premature ejaculation treatment involves the use of medication or therapy to address and manage the symptoms of premature ejaculation. This type of treatment encompasses the application of medicines or therapeutic interventions to tackle and alleviate premature ejaculation.

The main types of premature ejaculation treatments include antidepressants (SSRIs), phosphodiesterase-5 inhibitors, topical anesthetics, analgesics, and other therapeutic options. Selective serotonin reuptake inhibitors (SSRIs) are a class of antidepressant medications commonly used for treating depression. These treatments can be administered orally or topically and may be obtained through retail or direct-to-consumer channels. Various applications for premature ejaculation treatments include hospitals, retail pharmacies, online pharmacies, and other healthcare settings.

The premature ejaculation treatment market research report is one of a series of new reports from The Business Research Company that provides premature ejaculation treatment market statistics, including premature ejaculation treatment industry global market size, regional shares, competitors with a premature ejaculation treatment market share, detailed premature ejaculation treatment market segments, market trends and opportunities, and any further data you may need to thrive in the premature ejaculation treatment industry. This premature ejaculation treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The premature ejaculation treatment market size has grown strongly in recent years. It will grow from $3.53 billion in 2023 to $3.88 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth observed in the historical period can be attributed to various factors, including the increasing prevalence of premature ejaculation, a rise in awareness and reduced stigma surrounding the condition, efforts in physician and patient education, evolving societal attitudes toward sexual health, the expansion of telemedicine services, and initiatives from the pharmaceutical industry.

The premature ejaculation treatment market size is expected to see strong growth in the next few years. It will grow to $5.62 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The anticipated growth in the forecast period can be attributed to a continued focus on sexual health, the adoption of individualized treatment approaches, global efforts to address sexual dysfunction, the proliferation of online health platforms and apps, and increased openness in healthcare discussions. Major trends expected in the forecast period include a rise in behavioral and psychosexual therapies, the development of novel topical therapies, advancements in pharmacological treatments, the integration of telemedicine and online platforms, a focus on patient education and counseling, and ongoing research on novel mechanisms of action for premature ejaculation treatment.

The growing prevalence of sexual disorders is anticipated to drive the growth of the premature ejaculation treatment market. Sexual disorders or dysfunctions encompass difficulties faced by both men and women during any phase of regular intimate activity. Premature ejaculation, a specific sexual disorder, is addressed through treatment options involving medications or therapeutic approaches. For example, a November 2021 survey of 2,000 UK adults conducted by Pharmacy Direct GB, a UK-based online pharmacy, revealed that approximately 48% of UK residents reported experiencing erectile dysfunction, representing around 16.5 million individuals. The National Health Service spent over $17.9 million (£13 million) on Erectile Dysfunction treatment prescriptions in 2021. Additionally, a July 2022 survey of 1,000 men across the UK by Click2Pharmacy, a UK-based provider of local prescription treatment services, found that around 58.2% experienced erectile dysfunction in the UK, with 3 in 4 men between the ages of 25 and 34 experiencing erectile dysfunction in 2022. Thus, the increasing prevalence of sexual disorders is contributing to the growth of the premature ejaculation treatment market.

The rise in awareness about sexual health is expected to further fuel the growth of the premature ejaculation treatment market. Sexual health encompasses holistic well-being, including the physical, emotional, cognitive, and social dimensions of one's sexuality. Increased awareness about sexual health is crucial for effective premature ejaculation treatment, fostering understanding, communication, and informed decision-making. In October 2023, the UK Health Security Agency, a UK-based government agency, reported a notable increase in consultations at sexual health services (SHSs), reaching a total of 4,394,404 in 2022. This represented an 8.2% rise from the previous year, with the count standing at 4,059,608 in 2021. Therefore, the growing awareness about sexual health is playing a significant role in propelling the growth of the premature ejaculation treatment market.

A lack of effective treatment options is anticipated to impede the growth of the premature ejaculation treatment market. Inadequate treatment choices may lead to suboptimal outcomes for individuals dealing with premature ejaculation, hampering their ability to achieve effective management and control of the condition. For example, a May 2023 report from the National Center for Biotechnology Information, a US-based government library of medicine, indicated that premature ejaculation treatment success rates ranged from 30% to 70%, with frequent relapses requiring lifelong therapy for some men. Consequently, the absence of effective treatment options is a limiting factor for the growth of the premature ejaculation treatment market.

Key companies in the premature ejaculation treatment market are focusing on developing new solutions, such as delay sprays, to drive revenues. Delay sprays are specially formulated products applied to the penis before sexual activity to help men last longer during intercourse. They work by temporarily dulling penis nerves, reducing penis sensitivity, and delaying ejaculation. For instance, in August 2023, Maude, a US-based sexual wellness company, introduced Stay, a delay spray explicitly designed to address premature ejaculation. This product contains 10% lidocaine, a fast-evaporating local anesthetic that reduces sensitivity in the male genital region. Stay is compatible with both latex and polyisoprene condoms, various lubricants, and devices. It is vegan-friendly, fragrance-free, and free from sulfates, silicones, and parabens.

In November 2021, ANI Pharmaceuticals Inc., a US-based pharmaceutical company, acquired Novitium Pharma LLC for an undisclosed amount. This acquisition aimed to enhance ANI Pharmaceuticals' capabilities in research and development and increase generic manufacturing capacity. Novitium Pharma LLC is a US-based provider of selective serotonin reuptake inhibitors (SSRIs), including paroxetine used for premature ejaculation.

Major companies operating in the premature ejaculation treatment market report are Pfizer Inc., Johnson & Johnson, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Menarini Group, Lupin Limited., Amneal Pharmaceuticals Inc., Mankind Pharma Ltd., Cipla Limited, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Ltd., ANI Pharmaceuticals Inc., Sagent Pharmaceuticals Inc., Vivus Inc., Absorption Pharmaceuticals LLC, Innovus Pharmaceuticals Inc., Sunrise Pharmaceuticals Inc., Solco Healthcare US LLC, Apricus Biosciences Inc., Regent Pacific Group Limited, Endurance RP Ltd.

North America was the largest region in the premature ejaculation treatment market in 2023, and is expected to be the fastest-growing region in the forecast period. The regions covered in the premature ejaculation treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the premature ejaculation treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The premature ejaculation treatment market includes revenues earned by entities by providing services such as psychological therapy, cognitive-behavioral therapy and behavioral therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The premature ejaculation treatment market consists of sales of medications, inhibitors and drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Premature Ejaculation Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on premature ejaculation treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for premature ejaculation treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The premature ejaculation treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Antidepressants (SSRIs); Phosphodiesterase-5 Inhibitors; Topical Anesthetics; Analgesics; Other Treatment
2) By Route of Administration: Oral; Topical
3) By Distribution Channel: Retail; Direct-To-Consumer
4) By Application: Hospital; Retail Pharmacy; Online Pharmacy; Other Applications
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co Inc.; AbbVie Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r16314

1. Executive Summary

2. Premature Ejaculation Treatment Market Characteristics

3. Premature Ejaculation Treatment Market Trends And Strategies

4. Premature Ejaculation Treatment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Premature Ejaculation Treatment Market Size and Growth

5.1. Global Premature Ejaculation Treatment Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Premature Ejaculation Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Premature Ejaculation Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Premature Ejaculation Treatment Market Segmentation

6.1. Global Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Antidepressants (SSRIs)
Phosphodiesterase-5 Inhibitors
Topical Anesthetics
Analgesics
Other Treatment
6.2. Global Premature Ejaculation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Topical
6.3. Global Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Retail
Direct-To-Consumer
6.4. Global Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital
Retail Pharmacy
Online Pharmacy
Other Applications

7. Premature Ejaculation Treatment Market Regional And Country Analysis

7.1. Global Premature Ejaculation Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Premature Ejaculation Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Premature Ejaculation Treatment Market

8.1. Asia-Pacific Premature Ejaculation Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Premature Ejaculation Treatment Market

9.1. China Premature Ejaculation Treatment Market Overview
9.2. China Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Premature Ejaculation Treatment Market

10.1. India Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Premature Ejaculation Treatment Market

11.1. Japan Premature Ejaculation Treatment Market Overview
11.2. Japan Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Premature Ejaculation Treatment Market

12.1. Australia Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Premature Ejaculation Treatment Market

13.1. Indonesia Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Premature Ejaculation Treatment Market

14.1. South Korea Premature Ejaculation Treatment Market Overview
14.2. South Korea Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Premature Ejaculation Treatment Market

15.1. Western Europe Premature Ejaculation Treatment Market Overview
15.2. Western Europe Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Premature Ejaculation Treatment Market

16.1. UK Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Premature Ejaculation Treatment Market

17.1. Germany Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Premature Ejaculation Treatment Market

18.1. France Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Premature Ejaculation Treatment Market

19.1. Italy Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Premature Ejaculation Treatment Market

20.1. Spain Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Premature Ejaculation Treatment Market

21.1. Eastern Europe Premature Ejaculation Treatment Market Overview
21.2. Eastern Europe Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Premature Ejaculation Treatment Market

22.1. Russia Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Premature Ejaculation Treatment Market

23.1. North America Premature Ejaculation Treatment Market Overview
23.2. North America Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Premature Ejaculation Treatment Market

24.1. USA Premature Ejaculation Treatment Market Overview
24.2. USA Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Premature Ejaculation Treatment Market

25.1. Canada Premature Ejaculation Treatment Market Overview
25.2. Canada Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Premature Ejaculation Treatment Market

26.1. South America Premature Ejaculation Treatment Market Overview
26.2. South America Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Premature Ejaculation Treatment Market

27.1. Brazil Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Premature Ejaculation Treatment Market

28.1. Middle East Premature Ejaculation Treatment Market Overview
28.2. Middle East Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Premature Ejaculation Treatment Market

29.1. Africa Premature Ejaculation Treatment Market Overview
29.2. Africa Premature Ejaculation Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Premature Ejaculation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Premature Ejaculation Treatment Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Premature Ejaculation Treatment Market Competitive Landscape And Company Profiles

30.1. Premature Ejaculation Treatment Market Competitive Landscape
30.2. Premature Ejaculation Treatment Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Merck & Co Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. AbbVie Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bayer AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Premature Ejaculation Treatment Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. AstraZeneca PLC
31.3. GlaxoSmithKline plc
31.4. Takeda Pharmaceutical Company Limited
31.5. Eli Lilly and Company
31.6. Teva Pharmaceutical Industries Ltd.
31.7. Sandoz International GmbH
31.8. Sun Pharmaceutical Industries Ltd.
31.9. Menarini Group
31.10. Lupin Limited.
31.11. Amneal Pharmaceuticals Inc.
31.12. Mankind Pharma Ltd.
31.13. Cipla Limited
31.14. Alembic Pharmaceuticals Limited
31.15. Torrent Pharmaceuticals Ltd.

32. Global Premature Ejaculation Treatment Market Competitive Benchmarking

33. Global Premature Ejaculation Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Premature Ejaculation Treatment Market

35. Premature Ejaculation Treatment Market Future Outlook and Potential Analysis

35.1 Premature Ejaculation Treatment Market In 2028 - Countries Offering Most New Opportunities
35.2 Premature Ejaculation Treatment Market In 2028 - Segments Offering Most New Opportunities
35.3 Premature Ejaculation Treatment Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer